Diabetes Mellitus
📧 Sign up to get email alerts when something new happens for Diabetes Mellitus.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2019-10-15Clinical Trial Update: Clinical Usability of Intranasal Glucagon in Treatment of Hypoglycemia [Phase 3]
Phase 3 trial update on the clinical usability of intranasal glucagon for treating hypoglycemia in diabetes.
-
CLINICAL_TRIALS trial_result · 2019-10-10Clinical Trial Update: Impact of INsulin Sensitivity on Cardiovascular Risk Markers During 10-20 Years of FOllow up
A completed long-term clinical trial investigated how insulin sensitivity relates to cardiovascular risk markers over 10–20 years of follow-…
-
CLINICAL_TRIALS trial_result · 2019-10-08Clinical Trial Update: A Study of Nasal Glucagon (LY900018) in Japanese Participants With Diabetes Mellitus [Phase 3]
Phase 3 trial update for nasal glucagon (LY900018) in Japanese participants with diabetes mellitus, completed with results posted in 2019.
-
CLINICAL_TRIALS trial_result · 2019-10-01Clinical Trial Update: Inpatient Diabetes on Corticosteroids [Phase 4]
Phase 4 clinical trial update on inpatient diabetes management during corticosteroid use; results completed and posted.
-
CLINICAL_TRIALS trial_result · 2019-09-23Clinical Trial Update: A Study to Compare Rosuvastatin/Ezetimibe and Rosuvastatin in Patients With Diabetes Mellitus and Hypercholesterolemia [Phase 4]
A Phase 4 trial comparing Rosuvastatin/Ezetimibe versus Rosuvastatin in patients with diabetes and high cholesterol has completed.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2019-09-17Clinical Trial Update: Safety and Efficacy of Inhaled Insulin in Patients With Diabetes and Asthma or COPD [Phase 3]
Phase 3 trial update assessing safety and efficacy of inhaled insulin in patients with diabetes and asthma or COPD.
-
CLINICAL_TRIALS trial_result · 2019-09-16Clinical Trial Update: Improving Health in Diabetes Project [NA]
Completed clinical trial investigating improving health in diabetes; results posted in 2019.
-
FDA approval · 2019-09-10FDA Approved: GVOKE HYPOPEN 0.5 MG AUTO-INJECTOR — Original Application (Xeris Pharmaceuticals, Inc.)
FDA approved GVOKE HYPOPEN 0.5 mg Auto-Injector (glucagon injection, solution) from Xeris Pharmaceuticals in an original application (NDA212…
-
FDA approval · 2019-09-09FDA Approved: GLUCAGON — Supplemental Application (Fresenius Kabi USA, LLC)
The FDA approved a supplemental application for GLUCAGON submitted by Fresenius Kabi USA, LLC. The approval updates labeling and/or administ…
-
CLINICAL_TRIALS trial_result · 2019-09-09Clinical Trial Update: Improving Neuropathy and Mobility in People With Early Diabetes [NA]
Clinical trial completed evaluating interventions to improve neuropathy and mobility in people with early diabetes.
-
CLINICAL_TRIALS trial_result · 2019-09-06Clinical Trial Update: Preventing Microalbuminuria in Type 2 Diabetes [Phase 3]
Phase 3 clinical trial update focusing on preventing microalbuminuria in type 2 diabetes.
-
CLINICAL_TRIALS trial_result · 2019-09-06Clinical Trial Update: Evaluate the Immunogenicity of a Novel Glucagon Formulation [Phase 3]
Phase 3 trial evaluating immunogenicity of a novel glucagon formulation; study completed with results posted in 2019.
-
CLINICAL_TRIALS trial_result · 2019-08-28Clinical Trial Update: Randomized Evaluation of Anagliptin Versus Sitagliptin On Low-density lipoproteiN Cholesterol in Diabetes Trial [Phase 4]
Phase 4 randomized trial comparing anagliptin with sitagliptin on LDL cholesterol in diabetes patients has completed.
-
CLINICAL_TRIALS trial_result · 2019-08-28Clinical Trial Update: Investigations of the Optimum Serum Bicarbonate Level in Renal Disease. [NA]
A completed clinical trial investigating the optimum serum bicarbonate level in renal disease; results posted in 2019.
-
FDA approval · 2019-08-22FDA Approved: HUMULIN R — Supplemental Application (Eli Lilly and Company)
The FDA approved a supplemental application for Humulin R (insulin human) from Eli Lilly. The approval corresponds to changes described in t…
-
FDA approval · 2019-08-22FDA Approved: HUMULIN N — Supplemental Application (Eli Lilly and Company)
FDA approved a supplemental application for HUMULIN N (insulin human) submitted by Eli Lilly and Company.
-
CLINICAL_TRIALS trial_result · 2019-08-20Clinical Trial Update: A Pivotal Study to Evaluate Enlite™ Sensor Performance With iPro™2 in China [NA]
A pivotal study evaluating Enlite sensor performance with iPro2 in China has been completed, with results posted in 2019.
-
FDA approval · 2019-08-13FDA Approved: HUMALOG KWIKPEN — Supplemental Application (Eli Lilly and Company)
FDA approved a supplemental application for HUMALOG KWIKPEN (insulin lispro) from Eli Lilly and Company.
-
CLINICAL_TRIALS trial_result · 2019-08-07Clinical Trial Update: Empagliflozin Versus Sitagliptin Therapy for Improvement of Myocardial Perfusion Reserve in Diabetic Patients With Coronary Artery Disease [Phase 4]
Phase 4 trial comparing empagliflozin to sitagliptin for improvement of myocardial perfusion reserve in diabetic patients with coronary arte…
-
CLINICAL_TRIALS trial_result · 2019-08-02Clinical Trial Update: A Study to Evaluate THR-317 and Ranibizumab Combination Treatment for Diabetic Macular Oedema (DME) [Phase 2]
Phase 2 trial assessing the combination of THR-317 and Ranibizumab for diabetic macular edema has completed.
-
FDA approval · 2019-07-24FDA Approved: BAQSIMI — Original Application (Amphastar Pharmaceuticals, Inc.)
FDA approved BAQSIMI (glucagon) from Amphastar Pharmaceuticals in an Original Application for the treatment of severe hypoglycemia in people…
-
CLINICAL_TRIALS trial_result · 2019-07-24Clinical Trial Update: Safety and Efficacy of Relamorelin Administered to Participants With Vomiting Symptoms and Moderate to Severe Diabetic Gastroparesis [Phase 2]
Phase 2 clinical trial evaluating safety and efficacy of relamorelin in participants with vomiting symptoms and moderate to severe diabetic …
-
CLINICAL_TRIALS withdrawal · 2019-07-24Clinical Trial Update: Effect of Intracameral Dexamethasone After Phacoemulsification in Diabetics on Corneal Endothelial Cell Density [Phase 4]
Phase 4 clinical trial investigating intracameral dexamethasone after cataract surgery in diabetics was withdrawn.
-
CLINICAL_TRIALS withdrawal · 2019-07-24Clinical Trial Update: Pharmacokinetics of Antiplatelet Drugs in Diabetic pAtients [Phase 4]
A Phase 4 pharmacokinetics trial of antiplatelet drugs in diabetic patients was withdrawn.
-
CLINICAL_TRIALS trial_result · 2019-07-16Clinical Trial Update: Evaluating the User Performance and Experience of Nucleus Pen vs. Commercially Available Pen Needle [NA]
A completed clinical trial comparing user performance and experience between the Nucleus Pen and a commercially available pen needle in diab…